Shiddiky Laboratory
Back to News
November 01, 2024
From Ethiopia to Australia: Milkiyas Tantu’s journey into molecular diagnostics
Ethiopian researcher Milkiyas Tantu's journey from local diagnostic challenges to global health impact, developing early detection tools for fatty liver disease at the Shiddiky Laboratory at Charles Sturt University.
By Shiddiky Laboratory
From Ethiopia to Australia: Milkiyas Tantu’s journey into molecular diagnostics

Growing up in Ethiopia, I was always interested in health sciences. After high school, I pursued a degree in medical laboratory science at Hawassa University, graduating in 2008. My first job was at Dubbo St. Mary Hospital’s diagnostic laboratory, where I worked for six years. It was a valuable experience, but I quickly realized the limitations of our approach to diagnosing diseases. We often had to rely on symptom-based treatments, especially in microbiology, due to a lack of diagnostic options. Witnessing this gap drove me to explore microbiology and molecular diagnostics further.

To broaden my knowledge, I pursued a master’s degree in medical microbiology at Jimma University in Ethiopia, focusing on antimicrobial resistance in children. During my research, I collaborated with scientists at the Armauer Hansen Research Institute, Ethiopia’s leading medical research center. This experience solidified my desire to pursue a career in molecular diagnostics research and academia. In 2017, I joined Debre Markos University in Ethiopia as a lecturer and researcher, which opened up great opportunities to advance my interest in diagnostics.

In early 2024, I moved to Australia to join a research team at the Shiddiky Laboratory at Charles Sturt University under the guidance of Professor Mohammad J.A. Shiddiky and Professor Allen G. Ross. We are working on a project to develop an early diagnostic tool for metabolic dysfunction-associated fatty liver disease (MASLD). This disease is complex, influenced by genetics, lifestyle, and metabolic factors. It is a fast-growing global issue, yet it often goes undiagnosed in its early stages. Our goal is to create a diagnostic method that can detect MASLD early, as early intervention can be life-changing. With Professor Shiddiky’s expertise in diagnostics and Professor Ross’s public health background, our team brings a unique and practical approach to the project.

Being part of this work is incredibly rewarding. Early diagnosis could transform how we manage fatty liver disease, improving countless lives. I am grateful for the opportunity to work alongside dedicated mentors on research that could have a lasting impact on my career in molecular diagnostics and the application of these methods in healthcare.

Shiddiky Laboratory
Research
Publications
News
Future Member
Contact
Copyright © 2024 Shiddiky Laboratory. All Rights Reserved. Designed & Developed by@abdnahid_